Previously, a substantial number of studies have indicated that inflammation-related mediators, such as C-reactive protein (CRP), procalcitonin (PCT) and interleukin-6 (IL-6), play an important role in the prediction of CRC prognosis. The gene discussed is IL6; the disease is colorectal carcinoma.